FR2361912A1 - Vaccin anti-fecondite a base de membrane pellucide solubilisee - Google Patents

Vaccin anti-fecondite a base de membrane pellucide solubilisee

Info

Publication number
FR2361912A1
FR2361912A1 FR7625200A FR7625200A FR2361912A1 FR 2361912 A1 FR2361912 A1 FR 2361912A1 FR 7625200 A FR7625200 A FR 7625200A FR 7625200 A FR7625200 A FR 7625200A FR 2361912 A1 FR2361912 A1 FR 2361912A1
Authority
FR
France
Prior art keywords
fertility
vaccine
zona pellucida
immunological control
solubilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7625200A
Other languages
English (en)
French (fr)
Other versions
FR2361912B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to FR7625200A priority Critical patent/FR2361912A1/fr
Publication of FR2361912A1 publication Critical patent/FR2361912A1/fr
Application granted granted Critical
Publication of FR2361912B1 publication Critical patent/FR2361912B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FR7625200A 1976-08-19 1976-08-19 Vaccin anti-fecondite a base de membrane pellucide solubilisee Granted FR2361912A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7625200A FR2361912A1 (fr) 1976-08-19 1976-08-19 Vaccin anti-fecondite a base de membrane pellucide solubilisee

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7625200A FR2361912A1 (fr) 1976-08-19 1976-08-19 Vaccin anti-fecondite a base de membrane pellucide solubilisee

Publications (2)

Publication Number Publication Date
FR2361912A1 true FR2361912A1 (fr) 1978-03-17
FR2361912B1 FR2361912B1 (enExample) 1980-04-18

Family

ID=9176997

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7625200A Granted FR2361912A1 (fr) 1976-08-19 1976-08-19 Vaccin anti-fecondite a base de membrane pellucide solubilisee

Country Status (1)

Country Link
FR (1) FR2361912A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0185034A4 (enExample) * 1984-06-08 1988-01-28 Univ Monash

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0185034A4 (enExample) * 1984-06-08 1988-01-28 Univ Monash

Also Published As

Publication number Publication date
FR2361912B1 (enExample) 1980-04-18

Similar Documents

Publication Publication Date Title
Kanekar et al. Responsibility of a rape victim in relation to her respectability, attractiveness, and provocativeness
GB1146830A (en) Dual contraceptive appliance with reversible proboscis
BE847686A (fr) Corps d'insertion oculaire pour le traitement de la siccite oculaire par deficience aqueuse,
IT1148443B (it) Lente endoculare per pazienti con degenerazioni della zone centrale della retina
ATE6466T1 (de) Autoklavierbare emulsionen.
ES401204A1 (es) Un procedimiento de preparacion de una emulsion "agua en aceite" estable y no reversible.
PT83255B (pt) Polipeptidos e anticorpos, caracteristicos do polilomavirus e suas aplicacoes no diagnostico "in vitro" na pervencao e ou na luta contra as infeccoes por papilomavirus
ES2026481T3 (es) Un dispositivo intravaginal.
BG95330A (bg) Контрастни средства
KR900005986A (ko) 항원용액중의 보조제로서 수산화아연 또는 수산화철의 용도, 및 이러한 보조제를 함유하는 항원용액
FR2361912A1 (fr) Vaccin anti-fecondite a base de membrane pellucide solubilisee
ES2053712T3 (es) Un antigeno proteico reactivo y fragmentos del mismo.
GB8827539D0 (en) Ophthalmic ultra violet absorptive emollient
GB1097102A (en) Improvements in or relating to combine harvesters
JPS5248441A (en) Memory system
FR2366019A1 (fr) Solution injectable de l-pyroglutamyl-l-histidyl -l-prolinamide
GB608059A (en) Improvements in and relating to sun spectacles
IT7828382A0 (it) Procedimento per l'applicazione di occhi di supporto su parti di costruzione da supportare in modo oscillabile.
FR2358896A1 (fr) Solution ophtalmique a teneur de chlorure de benzalkonium
GB910455A (en) Improvements in or relating to corneal lenses
IT1215408B (it) Dispositivo per l'adduzione dosata di lega leggera liquida nel cilindro di pressione.
JPS5297639A (en) Amplifier circuit
JPS5949758A (ja) 陰茎と同じ接触感のあるコンド−ム
SU595085A1 (ru) Поводковое торцовое приспособление
GB455840A (en) Improvements in and relating to massage belts

Legal Events

Date Code Title Description
ST Notification of lapse